http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114767828-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25202fe4a5c7293a0a5e07026316bf12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
filingDate 2022-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d0d7a0d6593fb7eb665ec9ee8816f65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bc2abf4db9537cf506e1cd4478c0a8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37b52fb15a160de0a33ed1f11813dc58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b045e8801c98b853c1d05d74067a4a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3bd2cdcac4b6eeb4e64a3ed1bcee7b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8a5a6ec71141370a3d6a38290f88c7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73f0ca64821619fd9797c7fe69da6318
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbcd7f0ec850e5942ad91bdce2633ec1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28c2e0d1733d7a26f76413b9b3c5dd33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a357c20b4e5c4806f9bef9804042389
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4670a8e08064244704f7ffc41e86066d
publicationDate 2022-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114767828-A
titleOfInvention Application of ixazomib in the preparation of anti-tick-borne encephalitis virus, West Nile virus, yellow fever virus and chikungunya virus infection drugs
abstract The invention relates to the technical field of medicine, and relates to the preparation of ixazomib (Ixazomib, MLN2238) against tick-borne encephalitis virus (TBEV), West Nile virus (WNV), yellow fever virus (YFV) and chikungunya virus (CHIKV) infection drug application. Anti-TBEV, WNV, YFV and CHIKV infection drugs are ixazomib as the only active ingredient, or a pharmaceutical composition containing ixazomib. Anti-TBEV, WNV, YFV and CHIKV infection drugs refer to the prevention or treatment of TBEV, Drugs for WNV, YFV and CHIKV infections.
priorityDate 2022-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID447843
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID64320
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11082
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12637
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12637
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID37124
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID37124
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID7160
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID182111
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID7159
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11082
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID109660
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID182111
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1506
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11089
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11084
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID64320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420321610
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID7160
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11089
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID7159
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25183872

Total number of triples: 63.